secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-211980
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q1 revenue down 6% to $27.9M; gross margin expands to 43.4%
--------------------------------------------------------------------------

- Revenue $27.9M (-6% YoY); recurring revenue $22.5M roughly flat.
- Gross margin 43.4% (up from 37.2% YoY); product gross margin record 52.4%, service margin record 25.5%.
- Net loss narrowed to $19.0M from $25.8M; cash $161M at quarter end.
- Reiterated FY 2026 revenue guidance $125-130M (5-9% growth) and non-GAAP gross margin low-to-mid 40%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000119312526211980/0001193125-26-211980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000119312526211980/om-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-211980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer